Cargando…
Renal and Cardiovascular Toxicities by New Systemic Treatments for Prostate Cancer
Prostate cancer (PC) is the most common male cancer in Western Countries. In recent years, the treatment of relapsed or metastatic disease had benefited by the introduction of a variety of new different drugs. In consideration of the relative long survival of PC patients, side effects of these drugs...
Autores principales: | Saltalamacchia, Giuseppe, Frascaroli, Mara, Bernardo, Antonio, Quaquarini, Erica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407336/ https://www.ncbi.nlm.nih.gov/pubmed/32630204 http://dx.doi.org/10.3390/cancers12071750 |
Ejemplares similares
-
Prognostic Role of Pathological Complete Response in Early Stage Epithelial Solid Tumors
por: Saltalamacchia, Giuseppe, et al.
Publicado: (2023) -
Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy)
por: Quaquarini, Erica, et al.
Publicado: (2020) -
Bilateral Breast Metastases from Epstein-Barr Virus-Associated Gastric Cancer during Pregnancy: Is There a Method to Its Madness?
por: Quaquarini, Erica, et al.
Publicado: (2020) -
The PI3K/AKT/mTOR and CDK4/6 Pathways in Endocrine Resistant HR+/HER2− Metastatic Breast Cancer: Biological Mechanisms and New Treatments
por: Presti, Daniele, et al.
Publicado: (2019) -
Patterns of treatment and outcome of palbociclib plus endocrine
therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast
cancer: a real-world multicentre Italian study
por: Palumbo, Raffaella, et al.
Publicado: (2021)